Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rifapentin Dispersible Tablets

Approval Number

国药准字H20120045

Company山东鲁抗医药股份有限公司

Registration Date

January 18, 2022

Previous Approval Numbers

国药准字H20120045

Drug Information

Generic Name

利福喷丁分散片

Dosage Form

片剂

Strength

0.15g

Drug Type

化学药品

Registration Date

January 18, 2022

Company Information

Applicant Company

Company Name山东鲁抗医药股份有限公司

Company Address

山东省济宁高新区德源路88号

Manufacturing Company

Company Name山东鲁抗医药股份有限公司

Company Address

山东省济宁高新区德源路88号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy